Hsueh F W, Walker C M, Blackbourn D J, Levy J A
Department of Medicine, University of California, School of Medicine, San Francisco 94143.
Cell Immunol. 1994 Dec;159(2):271-9. doi: 10.1006/cimm.1994.1313.
CD8+ cell clones have been derived from peripheral blood mononuclear cells of human immunodeficiency virus (HIV)-infected and uninfected individuals. Several of these cloned cells have the ability to suppress HIV replication when cocultured with CD4+ cells acutely infected in the laboratory with HIV or with infected CD4+ cells from infected subjects. Suppression of virus production occurs without killing the target cells. With the CD8+ cell clones studied, this antiviral response correlated with production of a filterable factor that has antiviral activity. These cell clones offer the opportunity for identification of the factor mediating suppression of HIV replication. Moreover, adoptive transfer of cell clones might provide a valuable therapeutic approach for HIV-infected individuals.
已从感染和未感染人类免疫缺陷病毒(HIV)个体的外周血单个核细胞中获得CD8 +细胞克隆。其中一些克隆细胞在与实验室中急性感染HIV的CD4 +细胞或与来自感染受试者的感染CD4 +细胞共培养时,具有抑制HIV复制的能力。病毒产生的抑制在不杀死靶细胞的情况下发生。在所研究的CD8 +细胞克隆中,这种抗病毒反应与具有抗病毒活性的可过滤因子的产生相关。这些细胞克隆为鉴定介导HIV复制抑制的因子提供了机会。此外,细胞克隆的过继转移可能为HIV感染个体提供一种有价值的治疗方法。